Phase3 study of T-1220 in the patients with bacterial infectious disease-Open label, multi-center study-
Latest Information Update: 11 Oct 2018
At a glance
- Drugs Piperacillin (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Toyama Chemical
- 06 Jun 2016 New trial record